4002:TADAWULMouwasat Medical Services Co. Analysis

The stock is currently trading below its short‑term and medium‑term moving averages, and the MACD has turned bearish while the RSI sits in a neutral zone, suggesting a short‑term downside bias despite a moderate 30‑day volatility and a very low beta that limits large swings. Price action respects a clear support level near the lower end of its recent range, while resistance sits just above the current level, and volume has remained stable, indicating no immediate surge of buying pressure.
Fundamentally, the company posts a PE multiple well under the industry average and delivers robust operating margins, strong free cash flow and a dividend yield that ranks among the highest in the market. However, a discounted cash flow model places intrinsic value considerably below the market price, flagging an overvaluation risk. The earnings growth, solid cash generation and sustainable dividend make the stock a blend of growth and value attributes, but investors should weigh the valuation gap against the attractive income profile.